16x9
16x9 is an AI studio that builds and operates agentic companies, deploying AI agents to execute core operational workflows across clinical research, capital advisory, and commercial lending. The company runs a clinical-research site network where a sponsor development agent scans public trial registries daily, scores sponsor fit, and delivers research reports each morning. Its Mycel platform provides AI-powered integration and automation, connecting third-party services and executing configured workflows with all agent actions logged to audited ledgers.
- AI Agents
- Artificial Intelligence
- Financial Technology
- Enterprise Software
- Regulatory & Compliance Technology
- Software Only
- Data & Analytics
Funding
Founders
Founder details are not available yet.
Product
Problem
Clinical research institutions, capital advisory firms, and commercial lenders face significant operational inefficiencies in manual processes such as sponsor identification, document management, risk assessment, and content compliance. These knowledge-intensive workflows require substantial human effort, are prone to errors, and lack the scale needed to process large volumes of regulatory filings, trial registries, and financial documents.
Solution
16x9 operates as an AI studio that builds and runs agentic companies—companies where AI agents execute core operational workflows. The company develops specialized agents for each industry vertical: in clinical research, agents scan public trial registries to score sponsor fit and manage document workflows; in capital advisory, an intelligence engine processes SEC filings and news across six credibility axes; in commercial lending, a compliance-gated content engine generates drafts tied to a source registry. The Mycel platform, built by 16x9, provides AI-powered integration and automation that connects third-party services and executes configured workflows. All agent actions are logged to ledgers and audited, with systems categorized as running, pilot, or building based on production readiness.
Target Audience
Primary customers include clinical research site networks and sponsored-research networks, M&A/debt/real-estate advisory firms, and commercial lending businesses seeking AI-driven operational automation.
Features
- Sponsor development agent that scans public trial registries daily, scores sponsor fit, and shortlists targets
- Document agents that read, OCR, rename, and file shared drives with each move written to a ledger before it lands
- Intelligence engine processing SEC filings and news daily with six credibility axes and adversarial passes
- Public risk desk producing footnoted notes on jurisdiction pulses, license clocks, and ownership-opacity flags
- Firm operating system with six skills, three agents, and four tables, deployable via CLI
- Compliance-gated content engine that blocks unsourced claims before publication
- Mycel AI integration platform supporting Google sign-in, Google Workspace read-only directory access, and third-party service connectors
- Self-publishing website with a five-step AI chain (researcher, writer, auditor, grader, challenger) where nothing publishes without auditor approval and every article needs resolvable sources